Article Details

AstraZeneca's weekly-once diabetes drug gets US approval for children

Retrieved on: 2021-07-23 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's weekly-once diabetes drug gets US approval for children. View article details on hiswai:

Excerpt

July 23 (Reuters) - AstraZeneca Plc (AZN.L) said on Friday its diabetes drug Bydureon was approved in the United States for use in patients as young ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up